In the last 3 months. On the site you’ll find the news from the last 3 months. The older ones only have the title and a link, in file by topicsIt’s a support website for people with multiple myeloma. It aims to keep things simple and clear. MielomaAI As you may find.
Collected from Portuguese newspapers, Google News (PT, EN, ES, FR) and associations and scientific societies. They are on the website 197 news: only from the last 3 months. The older ones are only shown with the title and link, in file by topicsAnd research and the MielomaAI You continue to find them. Always consult the original news article and speak with your doctor before drawing conclusions about your case. Last update: November 17, 2026, 3:21 PM.
Tuesday, November 3rd
CELMoD Mechanisms and Immune Function in Multiple MyelomaCancerNetwork (EUA) · 15:19 OutrasEUAIn this segment, Dr. Joseph Mikhael and Dr. Scott Goldsmith introduce cereblon E3 ligase modulators (CELMoDs) and discuss their dual activity in multiple myeloma.
Tocilizumab Prophylaxis, Caregiver Readiness, and Chair Time Shape Community Bispecific Programs in R/R MyelomaOncLive (EUA) · 08:00 Doentes e associaçõesEUACommunity hematologists/oncologists discussed bispecific antibody integration in community practice for relapsed/refractory multiple myeloma.
Evidence Supporting MRD Negativity as a Prognostic and Regulatory Endpoint in Multiple MyelomaCancerNetwork (EUA) · 08:00 InvestigaçãoEUAIn this segment, Dr. Joseph Mikhael asks Dr. Scott Goldsmith to explain the evidence supporting the use of minimal residual disease (MRD) negativity as an endpoint for regulatory decision-making in multiple myeloma.
Outpatient Models and Prophylactic Measures Help Bring Bispecifics Into Community Practice for R/R MyelomaOncLive (EUA) · 08:00 Doentes e associaçõesEUAFaculty at an OncLive Scientific Interchange and Workshop discussed operationalizing outpatient bispecific antibody therapy for relapsed/refractory multiple myeloma.
T-Cell Fitness and Treatment Sequencing in Multiple MyelomaCancerNetwork (EUA) · 08:00 TratamentosEUAIn this segment, Dr. Joseph Mikhael and Dr. Scott Goldsmith discuss how T-cell fitness may influence treatment sequencing in multiple myeloma, particularly as chimeric antigen receptor (CAR) T-cell therapy and bispecific antibodies become increasingly important treatment options.
MRD Negativity and Its Clinical Significance in Multiple MyelomaCancerNetwork (EUA) · 08:00 InvestigaçãoEUAIn this segment, Dr. Joseph Mikhael, Dr. Paul Richardson, and Dr. Scott Goldsmith introduce the relationship between minimal residual disease (MRD) negativity and cereblon E3 ligase modulators (CELMoDs) in multiple myeloma, highlighting the role of MRD-negative complete response as an emerging regulatory endpoint.
Mapping Practical Steps to Expand CAR T-Cell Access in Multiple MyelomaCancerNetwork (EUA) · 08:00 Acesso e saúde públicaEUAJoshua Richter, MD, and Marco Davila, MD, PhD, discuss early evaluation, sequencing, referral partnerships, and access to CAR T-cell therapy in myeloma.
Imaging the Invisible: A New Precision Approach to Detecting Multiple MyelomaUniversity of Miami (EUA) · 08:00 InvestigaçãoEUAA phase 2 Sylvester trial found that CD38-targeted immunoPET can reveal active multiple myeloma missed by standard PET/CT.
Monday, 02/11
Frontline Treatment in Multiple Myeloma Is ChangingMedPage Today (EUA) · 08:00 TratamentosEUAExperts discuss the broader use of four-drug regimens and whether treatment can be shortened
Sunday, November 1st
Myeloma Is Many Diseases, and Treatment Must Reflect ThatThe American Journal of Managed Care (EUA) · 07:00 TratamentosEUANikhil C. Munshi, MD, says 25% to 30% of patients with myeloma may now be cured, but relapse and access remain challenges.
Thursday, October 29th
Can a Selinexor Quadruplet Treat Myeloma After T-Cell Redirecting Therapy?CancerNetwork (EUA) · 17:09 TratamentosEUA“If it is successful, you should be able to access this combination wherever you are,” said Natalie S. Callander, MD, of the UW Carbone Cancer Center.
Multiple myeloma: Cancer patient with 12 tumors finds hope as treatments advancefirstcoastnews.com (EUA) · 07:00 Doentes e associaçõesEUA
